ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Age Doesn’t Affect Survival After Bone Marrow Transplant

December 26, 2008

New Community Control Program May Be Developed

October 24, 1975

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

November 27, 2009

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991